z-logo
open-access-imgOpen Access
Can the COVID-19 interstate travel restrictions help lift the FDA’s blood ban?
Author(s) -
Doron Dorfman
Publication year - 2020
Publication title -
journal of law and the biosciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 18
ISSN - 2053-9711
DOI - 10.1093/jlb/lsaa009
Subject(s) - deferral , pandemic , stigma (botany) , political science , covid-19 , public health , economic shortage , medicine , business , development economics , economic growth , disease , economics , infectious disease (medical specialty) , finance , linguistics , philosophy , nursing , pathology , psychiatry , government (linguistics)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom